Richard Markham

Richard Markham

No open positions remaining
75 year
Health Technology
Finance
Consumer Services

Profile

Richard J.
Markham
formerly worked at Aventis Pharma AG, as Chief Executive Officer from 1999 to 2002, Hoechst Marion Roussel, Inc., as Chief Executive Officer, Acura Pharmaceuticals, Inc., as Non-Executive Chairman from 2006 to 2013, Aventis SA, as Vice Chairman & Chief Operating Officer in 2004, Vaxart, Inc., as Chairman, Medpace Research, Inc., as Chairman from 2007 to 2017, Cervelo Pharmaceuticals Ltd., as Chairman, Vaxart, Inc., as Chairman from 2009 to 2019, Sanofi Pasteur, Inc., as Director, CoLucid Pharmaceuticals, Inc., as Independent Director from 2008 to 2015, Marion Merrell Dow, Inc., as President, Chief Operating Officer & Director, Anacor Pharmaceuticals LLC, as Independent Director from 2011 to 2012, Pharmaceutical Research & Manufacturers Association, as Director, Merck & Co., Inc., as President & Chief Operating Officer from 1973 to 1993, Care Capital LLC, as Partner, and HealthCare Institute of New Jersey, as Trustee.
Dr. Markham received his undergraduate degree from Purdue University.

Former positions of Richard Markham

CompaniesPositionEnd
Private Equity Investor 08/05/2022
VAXART, INC. Chairman 30/11/2019
NEPHROGENEX INC Chairman 28/02/2017
COLUCID PHARMACEUTICALS INC Director/Board Member 27/10/2015
ACURA PHARMACEUTICALS, INC. Chairman 11/03/2013
See the detail of Richard Markham's experience

Training of Richard Markham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Distribution Services

Health Technology

Pharmaceutical Research & Manufacturers Association

Aventis Pharma AG

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Markham